Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Nanoviricides, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 28 | 33 | +5 |
| Shares | 909.5K | 957.8K | +48.3K (+5.3%) |
| Value | $4.22M | $4.44M | +$221.0K (+5.2%) |
New holders (8)
Institutions that held Nanoviricides, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 25,986 | $121.0K | 0.00% |
| Jane Street Group, LLC | 21,212 | $98.0K | 0.00% |
| Virtu Financial LLC | 19,793 | $92.0K | 0.01% |
| Marshall Wace, LLP | 11,037 | $51.0K | 0.00% |
| Cutler Group LP | 3,400 | $15.0K | 0.00% |
| FMR LLC | 50 | $0 | 0.00% |
| Belvedere Trading LLC | 28 | $0 | 0.00% |
| Walled Lake Planning & Wealth Management, LLC | 50 | $0 | 0.00% |
Sold out (3)
Institutions that held Nanoviricides, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Orion Portfolio Solutions, LLC | 31,931 | $148.0K |
| Wharton Business Group, LLC | 17,236 | $80.0K |
| Group One Trading, L.P. | 4,400 | $20.0K |